| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.564 | 19.901 | 19.217 | 15.596 | 12.174 | 10.539 | 9.536 | 8.817 | 7.731 | 9.035 |
| Total Income - EUR | 12.564 | 20.681 | 19.217 | 15.596 | 12.174 | 10.539 | 9.536 | 8.817 | 7.731 | 9.035 |
| Total Expenses - EUR | 10.421 | 16.603 | 13.520 | 11.628 | 9.812 | 7.731 | 6.572 | 6.407 | 5.985 | 7.235 |
| Gross Profit/Loss - EUR | 2.143 | 4.078 | 5.697 | 3.968 | 2.362 | 2.808 | 2.965 | 2.410 | 1.746 | 1.800 |
| Net Profit/Loss - EUR | 1.766 | 3.523 | 5.120 | 3.500 | 1.997 | 2.514 | 2.713 | 2.151 | 1.500 | 1.512 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - M.e. & M.o. Comimpex Nucet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.089 | 1.029 | 963 | 898 | 834 | 773 | 756 | 758 | 756 | 752 |
| Current Assets | 9.433 | 13.896 | 10.862 | 7.979 | 9.322 | 11.686 | 14.307 | 15.233 | 13.430 | 13.173 |
| Inventories | 8.710 | 13.204 | 9.857 | 5.894 | 5.950 | 5.833 | 5.923 | 5.095 | 4.678 | 3.079 |
| Receivables | 28 | 0 | 0 | 1.170 | 2.623 | 4.867 | 7.565 | 9.556 | 7.475 | 7.764 |
| Cash | 695 | 692 | 1.005 | 915 | 750 | 985 | 818 | 582 | 1.278 | 2.330 |
| Shareholders Funds | -3.894 | -331 | 4.795 | 8.207 | 10.044 | 12.368 | 14.807 | 4.563 | 6.049 | 7.527 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.416 | 15.256 | 7.030 | 670 | 112 | 91 | 256 | 11.429 | 8.137 | 6.398 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - M.e. & M.o. Comimpex Nucet Srl